Previous close | 375.000 |
Open | 375.000 |
Bid | 377.200 x 0 |
Ask | 377.400 x 0 |
Day's range | 373.800 - 379.600 |
52-week range | 260.200 - 401.000 |
Volume | |
Avg. volume | 24,467,097 |
Market cap | 3.552T |
Beta (5Y monthly) | 0.60 |
PE ratio (TTM) | 28.92 |
EPS (TTM) | 13.050 |
Earnings date | 14 Aug 2024 - 19 Aug 2024 |
Forward dividend & yield | 3.40 (0.91%) |
Ex-dividend date | 17 May 2024 |
1y target est | 467.59 |
Tencent-backed artificial intelligence (AI) drug researcher QuantumPharm is raising up to HK$1.13 billion (US$144.5 million) in a Hong Kong initial public offering (IPO) from Tuesday, eyeing the first listing under a new regime for pre-revenue specialist technology firms that was introduced more than a year ago. The Shenzhen-headquartered company, also known as XtalPi, is offering 187.37 million shares at HK$5.03 to HK$6.03 each. The shares will start trading on June 13. QuantumPharm is one of o
The best China stocks include Tesla archrival BYD as well as messaging and gaming giant Tencent and e-commerce leader PDD Holdings.
Tencent and its controlled entity Tencent Music will buy the stake through a combination of cash and a minority stake in music streaming app JOOX Thailand, valuing GMM Music at $700 million. In July 2023, GMM Music's parent company GMM Grammy approved a plan for spinning off the music unit and listing it on the Stock Exchange of Thailand. The deal will help GMM Music expand its business and fund innovation, the company said.